AHRQ Patient Safety Network

The Collection > Pharmacy

Narrow By

clear selections

Safety Target

•Device-related Complications (12)

•Diagnostic Errors (3)

•Identification Errors (4)

•Discontinuities, Gaps, and Hand-Off Problems (31)

•Medication Safety (340)

•Medical Complications (7)

•Surgical Complications (2)

•Transfusion Complications (1)

Origin/Sponsor

•Asia (7)

•Australia and New Zealand (11)

Resource Types

•Journal Article (200)

•Legislation/Regulation (11)

•Meeting/Conference (6)

•Newsletter/Journal (1)

•Newspaper/Magazine Article (56)

•Press Release/Announcement (22)

•Special or Theme Issue (4)

•Tools/Toolkit (17)

•Web Resource (8)

•Grant (1)

Error Types

•Epidemiology of Errors and Adverse Events (66)

•Active Errors (54)

•Latent Errors (28)

•Near Miss (6)

Approach to Improving Safety

•Quality Improvement Strategies (93)

•Legal and Policy Approaches (29)

•Error Reporting and Analysis (66)

•Communication Improvement (99)

•Human Factors Engineering (63)

•Teamwork (11)

•Specialization of Care (53)

•Logistical Approaches (16)

•Culture of Safety (25)

•Technologic Approaches (101)

•Education and Training (64)

Clinical Areas
< All

Pharmacy

•Hospital Pharmacy (83)

•Community Pharmacy (9)

Target Audience

•Health Care Providers (308)

•Health Care Executives and Administrators (237)

•Non-Health Care Professionals (107)

•Patients (48)

Setting of Care

•Hospitals (144)

•Psychiatric Facilities (1)

•Residential Facilities (8)

•Ambulatory Care (56)

1 - 20 of 351

Show ExcerptDon't Show Excerpt

dropdown

ORGANIZATIONAL POLICY/GUIDELINES

ISMP's Guidelines for Standard Order Sets.

Horsham, PA: Institute for Safe Medication Practices; March 2010.

SPECIAL OR THEME ISSUE

The safety and quality of health care: where are we now?

Med J Aust. 2006;184:S37-S72.

PRESS RELEASE/ANNOUNCEMENT

Patient Safety & Clinical Pharmacy Services Collaborative.

Rockville, MD: Health Resources and Services Administration.

COMMENTARY

The Role of the Patient in Improving Patient Safety

Gibson R. AHRQ WebM&M [serial online]. March 2007.

DATABASE/DIRECTORY

Horsham, PA: Institute for Safe Medication Practices; 2011.

FACT SHEET/FAQS classic

Preventing Medication Errors: A $21 Billion Opportunity.

Washington, DC: National Priorities Partnership and National Quality Forum; December 2010.

COMMENTARY

Developing a medication patient safety program — infrastructure and strategy.

Mark SM, Weber RJ. Hosp Pharm. 2007;42:149-156.

STUDY

Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.

Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA, for the HARM Study Group. Arch Intern Med. 2008;168:1890-1896.

STUDY

An assessment of the quality and impact of NPSA medication safety outputs issued to the NHS in England and Wales.

Lankshear A, Lowson K, Weingart SN. BMJ Qual Saf. 2011;20:360-365.

PRESS RELEASE/ANNOUNCEMENT

Promethazine HCl (marketed as Phenergan) Information.

FDA Alert [US Food and Drug Administration Web site]. April 25, 2006.

GRANT RECIPIENT

The MacArthur Fellows Program: Michael Cohen.

The John D. and Catherine T. MacArthur Foundation. September 20, 2005.

MEETING/CONFERENCE PROCEEDINGS

An Introduction to the Improved FDA Prescription Drug Labeling.

US Food and Drug Administration Center for Drug Evaluation and Research, Institute for Safe Medication Practices. November 7, 2006.

BOOK/REPORT

The Food and Drug Administration's National Drug Code Directory.

Office of the Inspector General. Washington, DC: US Department of Health and Human Services; August 2006. Report No. OEI-06-05-00060.

NEWSPAPER/MAGAZINE ARTICLE

JCAHO tightens leash on medication reconciliation.

Perry LE. Drug Topics: Health-System Edition. March 20, 2006.

NEWSPAPER/MAGAZINE ARTICLE

The five rights: a destination without a map.

ISMP Medication Safety Alert! Acute Care Edition. January 25, 2007;12:1.

COMMENTARY

Preventing harm from high-alert medications.

Federico F. Jt Comm J Qual Patient Saf. 2007;33:537-542.

COMMENTARY

Improving the safety of intravenous admixtures: lessons learned from a Pentostam® overdose.

Just S, Schepers G, Piotrowski MM, Saint S, Kauffman CA. Jt Comm J Qual Patient Saf. 2006;32:366-372.

CONGRESSIONAL TESTIMONY

Examining the Increase in Drug Shortages.

Hearings before the Subcommittee on Health of the Committee on Energy and Commerce Committee, 112th Cong, 1st Sess (September 23, 2011).

AUDIOVISUAL PRESENTATION

FDA MedWatch and Patient Safety Tutorial.

Silver Spring, MD: US Food and Drug Administration; October 2008.

COMMENTARY

Sidelining safety — the FDA's inadequate response to the IOM.

Smith SW. N Engl J Med. 2007;10:960-963.

1 2 3 4 5 6 7 8 9 10 11 Next >